Neuroblastoma UK
At a glance
- Innovation Grant: up to £5,000
Key takeaways
- Neuroblastoma UK suits projects that research new, more effective treatments for children with neuroblastoma, led from the UK or the Republic of Ireland, across basic research, clinical research, drug development and treatment synergies.
- It does not fund applications involving non-human primates, cats, dogs or equines, and Innovation Grants do not cover costs normally included in full applications, such as conference travel, so those should not be requested.
- Its grants are small: Innovation Grants go up to £5,000, and the annual report shows £7,142 awarded in the latest year, so a modest, well-costed request fits best.
- Timing depends on the route: the main research call is normally held every two years and advertised on its website, Innovation Grant applications are considered throughout the year, and the decision time is about 16 weeks.
- Proposals are reviewed by two or three specialist experts for scientific merit, likelihood of success and value to patients, Small Grant applications must add value to current neuroblastoma research, and a researcher may submit no more than one Small Grant application in two years.
Overview
Neuroblastoma UK is a charity registered with the Charity Commission for England and Wales (charity number 326385).
The Neuroblastoma Society was founded after the loss of the founders' son, with the aim of funding vital research into a devastating cancer and supporting other families experiencing neuroblastoma. The charity exists to facilitate research that will lead to more effective treatments and ultimately a cure for every child diagnosed with the disease. It has awarded 90 research grants and funded nearly £10 million of neuroblastoma research. Alongside its main research call, it allocates small amounts of funding through Innovation Grants of up to £5,000, which help researchers increase the impact of their work, explore synergies between separate research efforts and take forward new projects.
What they fund
Priority Areas
Neuroblastoma UK funds research projects intended to develop new, more effective treatments for children with neuroblastoma. Its portfolio includes basic research into how neuroblastomas develop, clinical and near-clinical research, and drug development with the potential to improve treatment protocols. It also considers studies of new therapeutic approaches, improvements to existing treatments and treatment synergies. Research led from the UK or Republic of Ireland is eligible. The charity assesses proposals for scientific merit, likelihood of success, potential value to neuroblastoma patients and available funds, using specialist peer review and its Scientific Advisory Board before trustees decide awards. It expects recipients to provide annual progress summaries and final project reports.
Themes
- Basic research
- Clinical research
- Drug development
- Treatment synergies
Geographic Focus
UK; Republic of Ireland.
What they don't fund
- Applications involving non-human primates, cats, dogs or equines
- Innovation Grant only: Costs that would normally be included in full grant applications such as support for travel to conferences
How to apply
For the main research call, trustees invite applications by public advertisement, typically on the charity's website, normally biennially. For Innovation Grants, download or request the form, then submit it to both grants@neuroblastoma.org.uk and research@neuroblastoma.org.uk, including the lead applicant's name in the email subject field.
Who can apply:
- Small Grants: Researchers in the UK or the Republic of Ireland. Current funding from Neuroblastoma UK is not a pre-requisite.
What to send:
- Small Grants: Small grant application form.
- Innovation Grants: All appendices listed.
Applying again: Small Grants: No more than one application should be submitted in a two-year period.
Application success factors
What the charity says:
- Projects are assessed for scientific merit, likelihood of success, potential value to neuroblastoma patients and available funds.
- Studies must pass rigorous scrutiny by two or three experts selected for specialist knowledge of the proposed research area.
- Small Grant applications must add value to current neuroblastoma research; the charity encourages synergies between separate research efforts.
- Recipients are expected to provide annual progress summaries and final project reports.
Where they fund
Where it says it funds
Similar funders
Funders supporting work similar to Neuroblastoma UK.
Five years of accounts
- Income
- £417,323
- Expenditure
- £121,683
- Grants paid
- —
- Income
- £268,417
- Expenditure
- £818,780
- Grants paid
- —
- Income
- £664,959
- Expenditure
- £151,102
- Grants paid
- —
- Income
- £303,350
- Expenditure
- £1,185,345
- Grants paid
- —
- Income
- £490,997
- Expenditure
- £89,273
- Grants paid
- £7,142
| Financial year | Income | Expenditure | Grants paid | Accounts document |
|---|---|---|---|---|
| year to 31 December 2021 | £417,323 | £121,683 | — | Accounts for year to 31 December 2021 |
| year to 31 December 2022 | £268,417 | £818,780 | — | Accounts for year to 31 December 2022 |
| year to 31 December 2023 | £664,959 | £151,102 | — | Accounts for year to 31 December 2023 |
| year to 31 December 2024 | £303,350 | £1,185,345 | — | Accounts for year to 31 December 2024 |
| year to 31 December 2025 | £490,997 | £89,273 | £7,142 | Accounts for year to 31 December 2025 |
- Grants paid, year to 31 December 2025: grants awarded in the year, as reported in the accounts.
— No grants figure for that year.
Figures from the charity’s filed accounts and its register entry. The document icon links to the charity’s entry on the Charity Commission register, where its filed accounts can be found.
Sources
Registers and filings
Other sources
- neuroblastoma.org.uk
- neuroblastoma.org.uk/research-approach · read on 30 October 2026
- neuroblastoma.org.uk/grants · read on 30 October 2026
- neuroblastoma.org.uk/research-faqs · read on 30 October 2026
- neuroblastoma.org.uk/s/Guidance-notes-for-Small-Grant-Applications-24.pdf · read on 30 October 2026
- neuroblastoma.org.uk/about · read on 30 October 2026
- neuroblastoma.org.uk/contact · read on 30 October 2026
- Annual report (year to 31 December 2025)
This profile draws on the funder’s own website as well as its filed accounts.
Sources last checked on 30 October 2026.
🎯 You've done the research. Now write an application they can't refuse.
Hinchilla combines funder's specific priorities with your organisation's past successful grants and AI analysis of what reviewers want to see.
Data privacy and security by default
Your organisation's past successful grants and experience
AI analysis of what reviewers want to see
A compelling draft application in 10 minutes instead of 10 hours
Spotted something that needs correcting? Let us know
At a glance
- Innovation Grant: up to £5,000

Applying to Neuroblastoma UK?
Hinchilla drafts your answers around this funder's priorities, using your organisation's own documents.
No credit card required
Contact
- 020 3096 7890source
- grants@neuroblastoma.org.uksource
- research@neuroblastoma.org.uksource
- hello@neuroblastoma.org.uksource
- Neuroblastoma UK, Canopi, 82 Tanner Street, London SE1 3GN, UKsource
- neuroblastoma.org.uk
- Contact form
- Apply online

Applying to Neuroblastoma UK?
Hinchilla drafts your answers around this funder's priorities, using your organisation's own documents.
No credit card required
Contact
- 020 3096 7890source
- grants@neuroblastoma.org.uksource
- research@neuroblastoma.org.uksource
- hello@neuroblastoma.org.uksource
- Neuroblastoma UK, Canopi, 82 Tanner Street, London SE1 3GN, UKsource
- neuroblastoma.org.uk
- Contact form
- Apply online